Literature DB >> 4160230

Immunofluorescence in cells derived from Burkitt's lymphoma.

G Henle, W Henle.   

Abstract

Henle, Gertrude (Children's Hospital of Philadelphia, Philadelphia, Pa.), and Werner Henle. Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol. 91:1248-1256. 1966.-Indirect immunofluorescence tests led to the brilliant staining of a small proportion of the cells in five different cultures derived from Burkitt's (African) lymphomas. The reaction was not restricted to the 17 sera from cases of this disease but extended to many sera from American individuals, whether healthy donors or patients suffering from a variety of illnesses. The incidence of positive sera increased with age from about 30% in childhood to > 90% in adults. Fluorescein-isothiocyanate-conjugated human gamma-globulins were suitable for direct staining of the same proportion of cells. The stained cells appeared to be in varying stages of degeneration, but cultural conditions leading to an increase in the cellular death rates failed to result in a rise in fluorescent cells. Several observations suggest that the stainable cells might be those which are seen to harbor virus particles under the electron microscope. Two cell lines derived from leukemic patients in this country also contained a small fraction of stainable cells but two others, and numerous primary human leukocyte cultures, gave consistently negative results. Attempts to relate the staining to known viral antigens have failed to implicate herpes simplex, varicella, cytomegalo, and reo viruses types 1, 2, and 3. The nature of the virus carried by the lymphoma cells as well as of the staining reactions remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4160230      PMCID: PMC316020          DOI: 10.1128/jb.91.3.1248-1256.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

1.  APPLICATION OF IMMUNOFLUORESCENCE TO THE STUDY OF HUMAN LEUKEMIA.

Authors:  M A FINK; R A MALMGREN; F J RAUSCHER; H C ORR; M KARON
Journal:  J Natl Cancer Inst       Date:  1964-09       Impact factor: 13.506

2.  A SECOND VIRUS-CARRYING TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; Y M BARR; B G ACHONG
Journal:  Pathol Biol       Date:  1964-12

3.  BURKITT TUMOR: TISSUE CULTURE, CYTOGENETIC AND VIRUS STUDIES.

Authors:  S E STEWART; E LOVELACE; J J WHANG; V A NGU
Journal:  J Natl Cancer Inst       Date:  1965-02       Impact factor: 13.506

4.  Preparation of a semipermanent mounting medium for fluorescent antibody studies.

Authors:  J RODRIGUEZ; F DEINHARDT
Journal:  Virology       Date:  1960-10       Impact factor: 3.616

5.  Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors:  J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

6.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

7.  EFFECTIVE TREATMENT OF EXPERIMENTAL HERPES SIMPLEX KERATITIS WITH NEW DERIVATIVE, 5-METHYLAMINO-2'-DEOXYURIDINE (MADU).

Authors:  M M NEMES; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

8.  THE BEHAVIOUR AND MORPHOLOGY OF A SECOND TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; Y M BARR; B G ACHONG
Journal:  Br J Cancer       Date:  1965-03       Impact factor: 7.640

9.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

10.  MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; G HENLE; B G ACHONG; Y M BARR
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more
  309 in total

1.  Mapping of B-cell epitopes on the polypeptide chain of the Epstein-Barr virus major envelope glycoprotein and candidate vaccine molecule gp340.

Authors:  R J Pither; C X Zhang; C Shiels; J Tarlton; S Finerty; A J Morgan
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

Review 2.  Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Authors:  Ralf D Hess
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  The role of lipoproteins in EBV early antigen induction in Raji cells.

Authors:  M Simon; I Melzner; B Bültmann
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.

Authors:  P R Band; P H Levine; V C Patwardhan; T K Shnitka; H F Pabst
Journal:  Can Med Assoc J       Date:  1973-01-20       Impact factor: 8.262

5.  Simplified radioimmunoassay for diagnostic serology.

Authors:  H D Hutchinson; D W Ziegler
Journal:  Appl Microbiol       Date:  1972-11

6.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

7.  Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.

Authors:  R Glaser; F Rapp
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

8.  Antigenic relationship between the herpesviruses of infectious bovine rhinotracheitis, Marek's disease, and Burkitt's lymphoma.

Authors:  D L Evans; J W Barnett; J M Bowen; L Dmochowski
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection.

Authors:  J Sample; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.